Vir Biotechnology Inc (VIR)
- Exchange
- NASDAQ
- Symbol
- VIR
- Sector
- Life Sciences
- Industry
- Biological Products, (no Disgnostic Substances)
- Description
- Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.
- Country
- USA
Stock price
At close: May 9, 2025
-
Open5.41
-
High5.45
-
Low5.08
-
Close5.09
-
Volume1,215,230
Financial ratios
Dec 31, 2024